Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $12.6 million.

  • NeuroPace's Cost of Revenue rose 2688.09% to $12.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year decrease of 2767.43%. This contributed to the annual value of $20.8 million for FY2024, which is 2035.96% up from last year.
  • According to the latest figures from Q3 2025, NeuroPace's Cost of Revenue is $12.6 million, which was up 2688.09% from $12.0 million recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Cost of Revenue ranged from a high of $12.6 million in Q3 2025 and a low of -$8.9 million during Q4 2024
  • For the 5-year period, NeuroPace's Cost of Revenue averaged around $4.6 million, with its median value being $4.1 million (2023).
  • The largest annual percentage gain for NeuroPace's Cost of Revenue in the last 5 years was 13674.3% (2024), contrasted with its biggest fall of 29917.17% (2024).
  • Quarter analysis of 5 years shows NeuroPace's Cost of Revenue stood at $2.9 million in 2021, then surged by 36.46% to $4.0 million in 2022, then increased by 12.07% to $4.5 million in 2023, then crashed by 299.17% to -$8.9 million in 2024, then surged by 241.6% to $12.6 million in 2025.
  • Its Cost of Revenue stands at $12.6 million for Q3 2025, versus $12.0 million for Q2 2025 and $5.2 million for Q1 2025.